| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $-0.0056 (Beat by $0.1044) |
| EPS GAAP Actual | $-0.0056 (Beat by $0.1044) |
| Revenue Actual | $0.134269B |
| Revenue Surprise | Beat by $134.269M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.14753 |
| EPS GAAP Estimate | $-0.14753 |
| Revenue Estimate | $0.1295576B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.06 | 567.83 | 0.0591385 | 0.06134741 | 1 |
| Dec 2028 | -0.34 | -100.21 | -0.34417 | -0.33691 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.01 | 0.12492 | 0.134269B | 13.67% | 2.18M |
| FQ2 2025 (Jun 2025) | -0.13 | 0.00284 | 0.136139B | 14.6% | 3.02M |
| FQ1 2025 (Mar 2025) | -0.14 | -0.14 | 0.12362B | 11.95% | 123.62M |
| FQ4 2024 (Dec 2024) | -0.33 | -0.33 | 0.124277B | 14.27% | 124.28M |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 0.11591B | 15.2% | 115.91M |
| FQ2 2024 (Jun 2024) | -0.17 | -0.17 | 0.116269B | 13.2% | 116.27M |
| FQ1 2024 (Mar 2024) | -0.28 | -0.28 | 0.108851B | 14.11% | 108.85M |
| FQ4 2023 (Dec 2023) | -0.21 | -0.21 | 0.106543B | 17.38% | 106.54M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.14753
Consensus Revenue Estimates
0.1295576B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.029 | -- | 0.02860698 | 0.02933232 | 2 |
| FQ3 2027 (Sep 2027) | -0.0205 | -- | -0.02073492 | -0.02022218 | 2 |
| FQ2 2027 (Jun 2027) | -0.0238 | -- | -0.02407273 | -0.02347746 | 2 |
| FQ1 2027 (Mar 2027) | -0.0635 | -- | -0.06422767 | -0.06263943 | 2 |
| FQ4 2026 (Oct 2026) | -0.10612 | -- | -0.10678 | -0.10527 | 3 |
| FQ3 2026 (Jul 2026) | -0.10797 | 90.74 | -0.10864 | -0.1071 | 3 |
| FQ2 2026 (Jun 2026) | -0.11268 | -15.37 | -0.11422 | -0.11106 | 3 |
| FQ1 2026 (Mar 2026) | -0.19518 | 28.27 | -0.19785 | -0.19238 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.17B | -- | 0.17B | 0.17B | 3 |
| FQ3 2027 (Sep 2027) | 0.16B | -- | 0.16B | 0.16B | 3 |
| FQ2 2027 (Jun 2027) | 0.16B | -- | 0.16B | 0.16B | 3 |
| FQ1 2027 (Mar 2027) | 0.15B | -- | 0.15B | 0.15B | 3 |
| FQ4 2026 (Oct 2026) | 0.14B | -- | 0.14B | 0.14B | 4 |
| FQ3 2026 (Jul 2026) | 0.15B | 8.74 | 0.15B | 0.15B | 4 |
| FQ2 2026 (Jun 2026) | 0.15B | 7.68 | 0.15B | 0.15B | 4 |
| FQ1 2026 (Mar 2026) | 0.14B | 8.95 | 0.13B | 0.14B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.13492 | -0.01 | 0.12492 | -1249.2% |
| FQ2 2025 (Jun 2025) | -0.13284 | -0.13 | 0.00284 | -2.18% |
| FQ1 2025 (Mar 2025) | -0.14 | -0.14 | 100% | |
| FQ4 2024 (Dec 2024) | -0.33 | -0.33 | 100% | |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 100% | |
| FQ2 2024 (Jun 2024) | -0.17 | -0.17 | 100% | |
| FQ1 2024 (Mar 2024) | -0.28 | -0.28 | 100% | |
| FQ4 2023 (Dec 2023) | -0.21 | -0.21 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.13B | $0.13B | $2.18M | 1.62% |
| FQ2 2025 (Jun 2025) | $0.13B | $0.14B | $3.02M | 2.22% |
| FQ1 2025 (Mar 2025) | $0B | $0.12B | $123.62M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.12B | $124.28M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.12B | $115.91M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.12B | $116.27M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.11B | $108.85M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.11B | $106.54M | 100% |